Cargando…
Antiproliferative effects of sorafenib and pegylated IFN-α2b on human liver cancer cells in vitro and in vivo
Novel therapeutic strategies are needed to treat patients with advanced hepatocellular carcinoma (HCC). Combination therapy of sorafenib and type I interferon (IFN) has substantial activity in patients with metastatic renal cell carcinoma. We investigated the antiproliferative effects of sorafenib i...
Autores principales: | KUSANO, HIRONORI, OGASAWARA, SACHIKO, AKIBA, JUN, NAKAYAMA, MASAMICHI, UEDA, KOSUKE, YANO, HIROHISA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699579/ https://www.ncbi.nlm.nih.gov/pubmed/23588838 http://dx.doi.org/10.3892/ijo.2013.1904 |
Ejemplares similares
-
Pegylated Interferon-α2a Inhibits Proliferation of Human Liver Cancer Cells In Vitro and In Vivo
por: Kusano, Hironori, et al.
Publicado: (2013) -
Effect of sorafenib on des-γ-carboxyprothrombin secretion by a human hepatocellular carcinoma cell line
por: Ogasawara, Sachiko, et al.
Publicado: (2017) -
Aldehyde Dehydrogenase 1 Identifies Cells with Cancer Stem Cell-Like Properties in a Human Renal Cell Carcinoma Cell Line
por: Ueda, Kosuke, et al.
Publicado: (2013) -
CD44v3(+)/CD24(−) cells possess cancer stem cell-like properties in human oral squamous cell carcinoma
por: TODOROKI, KEITA, et al.
Publicado: (2015) -
Impact of Gleason score of the tumor at the positive surgical margin as a prognostic factor
por: Kurose, Hirofumi, et al.
Publicado: (2022)